HenrichTJ, et al.Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation. J Infect Dis, 2013; 207:1694–1702.
2.
LuzuriagaK, et al.HIV Tpe 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1 infected children who receive early treatment. J Infect Dis, 2014; 210:1529–1538.
3.
OrenstinJM, et al.Macrophages as a source of HIV during opportunistic infections. Science, 1997; 276:1857–1861.
4.
PernoCFet al.Relative potency of protease inhibitors in monocytes/macrophages acutely and chronically infected with human immunodeficiency virus. J Infect Dis, 1998; 178:413–422.
5.
PersaudD, et al.Dynamics of the resting CD4+ T-cell latent HIV reservoir ininfants initiating HAART less than 6 months of age. AIDS, 2012; 26:1483–1490.
6.
Rainwater-LovettK, LuzuraigaK, PersaudD. Very early combination antiretroviral therapy in infants: prospects for cure. Curr Opin HIV AIDS, 2015; 101:4–11.
7.
ReynosoR, et al.HIV-1 induces telomerase activity in monocyte-derived macrophages–safeguarding one of its reservoirs?. J Virol, 2012; 86:10327–10337.
8.
SwinglerS, et al.Apoptotic killing of HIV-1 infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog, 2007; 3:1281–1290.
9.
TowersG, et al.Interactions between HIV-1 and the cell-autonomous innate immune system. Cell Host microbe, 2014; 16:10–18.
10.
YukiSA, et al.Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog, 2013; 9:e1003347.
11.
ZhuT. HIV-1 in peripheral blood monocytes: an underrated viral source. J Antimicrob Chemother, 2002; 50:309–311.
